SpaceX IPO is the biggest IPO in stock market history. Join the conversation.Click here

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksSVST.L Regulatory News (SVST)

  • There is currently no data for SVST

Offer Update

10 Dec 2007 07:01

OAO Severstal10 December 2007 10 December 2007 RECOMMENDED REVISED CASH OFFER BY CENTROFERVE LIMITED A WHOLLY OWNED SUBSIDIARY OF SEVERSTAL FOR CELTIC RESOURCES HOLDINGS PLC OFFER UNCONDITIONAL AS TO ACCEPTANCES Centroferve, a wholly owned subsidiary of Severstal, announces that, as at 3.00p.m. on Friday 7 December 2007, acceptances of the Offer had been received inrespect of 45,294,217 Celtic Shares (representing approximately 81.1% of theCeltic Shares to which the Offer relates) and that, accordingly, the Offer isunconditional as to acceptances. If the Offer is declared unconditional in all respects, Celtic Shareholders whohave accepted or accept the Offer while it remains open for acceptance willreceive aggregate cash consideration of £2.90 per Celtic Share becauseCentroferve has received acceptances of the Offer in respect of 80% in value ofthe Celtic Shares for which the Offer was made, and the contingent cashconsideration described in the Revised Offer Document has therefore becomepayable. Having received acceptances of the Offer in respect of 80% of the Celtic Sharesto which the Offer relates, if the Offer is declared unconditional in allrespects Centroferve intends to exercise its right pursuant to the provisions ofSection 204 of the Companies Act 1963 to acquire the remaining Celtic Shares towhich the Offer relates on the same terms as the Offer. Centroferve did not hold any Celtic Shares before the commencement of the OfferPeriod and has not acquired or agreed to acquire any Celtic Shares during theOffer Period. Prior to the Offer Period, Bluecone, a company owned by Severstal, acquired12,281,946 Celtic Shares, and during the Offer Period (but before the OriginalOffer was made) Bluecone acquired a further 4,301,056 Celtic Shares. As aresult, Bluecone owns 16,583,002 Celtic Shares representing approximately 29.7%of the issued share capital of Celtic, and the acceptances referred to aboveinclude an acceptance of the Offer by Bluecone in respect of all of the CelticShares held by Bluecone. Other than the Celtic Shares held or acquired by Bluecone, no party acting inconcert with Centroferve held before the commencement of the Offer Period, oracquired or agreed to acquire during the Offer Period, any Celtic Shares. Terms defined in the Revised Offer Document dated 20 November 2007 have the samemeaning in this announcement unless otherwise stated. The Offer remains open for acceptance until 3.00pm (Dublin time) on 28 December2007. Enquiries: Centroferve Tel: +7 495 9810 910 ext.6633 Roman Deniskin Nikolai Zelenski Morgan Stanley & Co. Limited Tel: +44 20 7425 8000 Peter Bacchus Arash Mahdaviani FD London Tel: +44 207 831 3113 Jon Simmons Ben Brewerton The directors of Centroferve and the directors of Severstal acceptresponsibility for the information contained in this announcement. To the bestof the knowledge and belief of the directors of Centroferve and the directors ofSeverstal (who have taken all reasonable care to ensure that such is the case),the information contained in this announcement for which they acceptresponsibility is in accordance with the facts and does not omit anything likelyto affect the import of such information. Morgan Stanley & Co. Limited ("Morgan Stanley") is acting exclusively forCentroferve and Severstal Resurs and no one else in connection with the Offerand Morgan Stanley will not regard any other person as a client in relation tothe Offer and will not be responsible to anyone other than Centroferve andSeverstal Resurs for providing the protections afforded exclusively to itsclients or for providing advice in relation to the Offer, the contents of thisannouncement or any transaction or arrangement referred to herein. The Offer will not be made, directly or indirectly, in or into any jurisdictionwhere it would be unlawful to do so, or by use of the mails, or by any means orinstrumentality (including, without limitation, telephonically orelectronically) of interstate or foreign commerce, or by any facility of anational securities exchange of any jurisdiction where it would be unlawful todo so, and the Offer will not be capable of acceptance by any such means,instrumentality or facility from or within any jurisdiction where it would beunlawful to do so. Accordingly, copies of this announcement and all otherdocuments relating to the Offer are not being, and must not be, mailed orotherwise forwarded, distributed or sent in, into or from any jurisdiction whereit would be unlawful to do so. Persons receiving such documents (including,without limitation, nominees, trustees and custodians) should observe theserestrictions. Failure to do so may invalidate any related purported acceptanceof the Offer. Notwithstanding the foregoing restrictions, Centroferve reservesthe right to permit the Offer to be accepted if, in its sole discretion, it issatisfied that the transaction in question is exempt from or not subject to thelegislation or regulation giving rise to the restrictions in question. This announcement does not constitute an offer to sell or an invitation topurchase or the solicitation of an offer to purchase or subscribe for anysecurities. Any response in relation to the Offer should be made only on thebasis of the information contained in the Revised Offer Document or any documentby which the Offer is made. Any person who is a holder of 1% or more of the Celtic Shares may havedisclosure obligations under Rule 8.3 of the Takeover Rules, effective from thedate of the commencement of the Offer Period. The Offer will be made in the United States pursuant to an exemption from the UStender offer rules provided by Rule 14d-1(c) under the US Exchange Act. Notice to US holders of Celtic Shares: The Offer will be made for the securities of an Irish public limited companywhose shares are listed on the AIM market in the UK and is subject to Irish andUK disclosure requirements, which are different from those of the United States.The Offer will be made in the United States pursuant to applicable US tenderoffer rules and otherwise in accordance with the requirements of the IrishTakeover Rules. Accordingly, the Offer will be subject to disclosure and otherprocedural requirements, including with respect to withdrawal rights, offertimetable, settlement procedures and timing of payments that are different fromthose applicable under US domestic tender offer procedures and law. The receipt of cash pursuant to the Offer by a US holder of Celtic Shares may bea taxable transaction for US federal income tax purposes and under applicable USstate and local, as well as foreign and other tax laws. Each holder of CelticShares is urged to consult his independent professional adviser immediatelyregarding the tax consequences of acceptance of the Offer. It may be difficult for US holders of Celtic Shares to enforce their rights andany claim arising out of the US federal securities laws, since Centroferve andCeltic are located in non-US jurisdictions, and some or all of their officersand directors may be residents of non-US jurisdictions. US holders of CelticShares may not be able to sue a non-US company or its officers or directors in anon-US court for violations of the US securities laws. Further, it may bedifficult to compel a non-US company and its affiliates to subject themselves toa US court's judgement. In accordance with normal Irish and UK practice and pursuant to Rule 14e-5(b) ofthe US Exchange Act, Centroferve or its nominees, or its brokers (acting asagents), may from time to time make certain purchases of, or arrangements topurchase, Celtic Shares outside the United States, other than pursuant to theOffer, before or during the period in which the Offer remains open foracceptance. These purchases may occur either in the open market at prevailingprices or in private transactions at negotiated prices. Any information aboutsuch purchases will be disclosed as required in Ireland and the UK, will bereported to a Regulatory Information Service of the UK Listing Authority andwill be available on the London Stock Exchange website, www.londonstockexchange.com. This information is provided by RNS The company news service from the London Stock Exchange
Date   Source Headline
16th Sep 20146:22 pmRNSCompletion of sale of Columbus and Dearborn
11th Sep 20147:00 amRNSResult of Extraordinary General Meeting
20th Aug 20141:01 pmRNSCompletion of PBS Coals sale
30th Jul 20148:14 amRNSAgenda for EGM
30th Jul 20147:00 amRNSQ2 & H1 2014 financial results
25th Jul 201412:58 pmRNSNotice of Q2 and H1 2014 financial results
21st Jul 20147:00 amRNSSeverstal Agrees to sell Columbus and Dearborn
15th Jul 20141:45 pmRNSAgreement for sale of PBS Coals
14th Jul 20143:40 pmRNSAnnouncement of EGM
14th Jul 20147:00 amRNSQ2 2014 and H1 2014 Operational results
1st Jul 201411:08 amRNSManagement Share Dealing Notification
11th Jun 20143:57 pmRNSResult of AGM
14th May 20144:02 pmRNSTender Offer Results
14th May 20141:26 pmRNSSeverstal response to media speculation
30th Apr 20147:00 amRNSSeverstal reports Q1 2014 financial results
30th Apr 20147:00 amRNSAgenda for AGM and dividend declaration
29th Apr 201412:26 pmRNSTender offer for the notes due to 2016 and 2017
28th Apr 201410:34 amRNSNotice of Q1 2014 financial results
17th Apr 201411:33 amRNS2013 Annual report
15th Apr 20147:00 amRNSTrading Statement
27th Feb 20147:00 amRNSQ4 & FY2013 Financial Results
25th Feb 20143:07 pmRNSRecommended Dividend and Date of AGM
24th Feb 20141:51 pmRNSNotice of Q4 & FY 2013 Results
6th Feb 201410:31 amRNSCapital Investment Program for 2014
23rd Jan 20147:00 amRNSQ4 2013 & FY 2013 Operational results
17th Jan 20141:03 pmRNSChange of Corporate Secretary
18th Dec 20137:00 amRNSResult of EGM
14th Nov 20137:13 amRNSQ3 & 9M 2013 financial results
12th Nov 20132:40 pmRNSDividend payment for the 9 months 2013
11th Nov 201312:29 pmRNSNotice of Q3 Results and Capital Markets Day
21st Oct 20137:00 amRNSAnnouncement of EGM
17th Oct 20137:00 amRNSQ3 2013 Operational Results
2nd Oct 20133:34 pmRNSRe-election of Chairman of the Board
30th Sep 20133:35 pmRNSResult of EGM
3rd Sep 20132:25 pmRNSManagement Changes at SNA
29th Aug 20137:00 amRNSQ2 & H1 2013 financial results
23rd Aug 201312:04 pmRNSNotice of Q2 and 1H 2013 financial results
23rd Jul 20137:00 amRNSQ2 2013 Operational results
18th Jul 20137:00 amRNSAnnouncement of EGM
15th Jul 20134:41 pmRNSManagement and organizational changes
17th Jun 20133:02 pmRNSRe-election of Chairman of the Board
13th Jun 20134:15 pmRNSResult of AGM
20th May 20137:00 amRNSSeverstal reports Q1 2013 financial results
16th May 20134:35 pmRNSDividend payment for Q1 2013
15th May 201311:15 amRNSNotice of Q1 2013 financial results
29th Apr 20132:05 pmRNSSeverstal publishes 2012 Annual Report
24th Apr 20133:25 pmRNSAgenda for AGM
22nd Apr 20137:00 amRNSQ1 2013 Operational results
19th Mar 20134:42 pmRNSIssue of Loan Participation Notes
15th Mar 20135:53 pmRNSPublication of Final Terms

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.